The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer
Yoshinobu Ohsaki(Asahikawa Medical University)
Cited by 7
Related Papers
Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer
|International Journal of Oncology|2017|34
SETD2 and miR-21 as therapeutic targets for NUT midline carcinoma
|Research Square|2021|0